An issue brief by ASTHO and the Duke University Margolis Center for Health Policy that highlights considerations for state health officials as they look to maximize the benefits of COVID-19 therapeutics.
As communities around the country continue to navigate the complexities of COVID-19 management and prevention this fall, reliable resources are needed for connecting public health leaders with the latest information on treatment. HHS's ...
With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To help navigate the new legislative ...
As the country prepares for the inauguration of President-Elect Joseph R. Biden, Jr. on Wednesday, the incoming administration has highlighted several priorities over the next four years. This post is a summary of priorities that are ...
As COVID spread through the country and infection rates rose in every state, many of the the U.S. Affiliated Pacific Islands (USAPI) received media attention for remaining relatively COVID-free. The USAPI’s unified response in the face of ...
There are a number of court cases playing out across the country that could affect the options state and territorial health officials have to limit the spread of disease and promote health and well-being.
States have largely dismissed weakening policies, but legislatures are likely to continue considering vaccine-related bills, which may allow public health leaders to work collaboratively toward improving vaccination rates and bolster the ...
ASTHO's mission is to support, equip, and advocate for state and territorial health officials in their work of advancing the public's health and well-being. To that end, here are the 12 most popular resources our members, partners, ...
A discussion with Meredith Allen, ASTHO’s Vice President for Health Security, about how the first shipments of the COVID-19 vaccinations have been a major turning point for the pandemic and a milestone moment for U.S. public health ...
In order to contain and mitigate the COVID-19 pandemic, widespread, rapid testing is key. Rampant and efficient testing determines who has the virus and who may be at risk of transmitting it, and allows for effective management of ...
Following a hurricane, the risk of exposure to infectious disease increases due, in part, to the presence of floodwater and debris. Hurricanes may contribute to population displacement and overcrowding—further heightening risk factors for ...
On Aug. 23, 2021, the FDA announced full approval of Pfizer and BioNTech’s mRNA vaccine for COVID-19. ASTHO has answers to five key questions about the approval and what it means for state and territorial health officials: What does the ...
If there is any word to describe 2020 it is “unprecedented,” with the work of health agencies front and center since COVID-19 emerged in the U.S. But as we approach Public Health Thank You Day and the Thanksgiving season, ASTHO wants to ...
Each year the U.S. battles seasonal influenza, leaving millions of people sick, hospitalized, or worse. As COVID-19 cases continue to rise, it is crucial for all eligible individuals to receive a flu vaccine to help reduce the likelihood ...
The disparities experienced during the COVID pandemic have brought a national focus to health equity in our nation. The attention and resources currently being provided to help address health inequities provide an opportunity that I have ...
Vaccines are one of the greatest public health achievements of the last century, as well as some of the most powerful and cost-effective tools to prevent disease, disparities, disability, and death among children and adults. The COVID-19 ...
Anticipating a rapid deployment of COVID-19 vaccines as they are authorized, the CDC developed COVID-19 Vaccination Program Operational Guidance in collaboration with state and local jurisdictions to outline how each jurisdiction will make ...
Recent state laws and governor emergency orders prohibiting universal school mask protocols are complicating the implementation of CDC’s evidence-based guidance for COVID-19 mitigation measures for in-person school. Ten states have enacted ...
As governments and private entities adopt COVID-19 vaccine protocols to protect health and safety, legal challenges are mounting. In some states, policymakers have proactively attempted to limit or prohibit adopting COVID-19 vaccine ...
Data reveals that nearly one third of COVID-19 patients experience one or more post-COVID conditions that linger for weeks or months after infection. The cause, duration, and potential treatments for these conditions are still being ...